A critical advance in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This essential cancer inhibitor protein is frequently lost in many types of cancer, leading uncontrolled https://thebookmarkfree.com/story22044052/vhh-fragments-restore-tumor-suppressor-p53-new-promising-pathway-for-tumor-management